Where is Sirona Dx located?

Sirona Dx is headquartered in Lake Oswego, United States.

How many employees does Sirona Dx have?

As of Jun 30, 2026, the latest employee count at Sirona Dx is 12.

Is Sirona Dx a funded company?

Sirona Dx is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Sirona Dx rank among its competitors?

Sirona Dx ranks 53rd amongst 619 active competitors, of which 61 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was ONCOHOST, which secured $2.8M in May, 2025.

Who are the top competitors of Sirona Dx?

Sirona Dx's top competitors include Strand Life Sciences, BGI and ONCOHOST. Among them, ONCOHOST secured the most recent funding round in May, 2025.

Sirona Dx - 2026 Company Profile, Team, Funding & Competitors

Sirona Dx is a funded company based in Lake Oswego (United States), founded in 2014 by Nasry Yassa. It operates as a Contract research organization offering a wide range of genomic services. The company has 619 active competitors, including 61 funded and 65 that have exited. Its top competitors include companies like Strand Life Sciences, BGI and ONCOHOST.

Company Details

Contract research organization offering a wide range of genomic services. It provides sequencing services in targeted sequencing, exome sequencing, SNP genotyping, Pharmacogenomics, HLA typing, and other genomic services. Additionally, the company also offers pharma services such as custom assay development, clinical trial services, and bioinformatics.

Website: sironadx.com
Email ID: *****@sironadx.com

Key Metrics

Founded Year

2014

Location

Lake Oswego, United States

Stage

Funding Raised

Investors

OTRADI

Ranked

53^rd among 619 active competitors

Employee Count

12 as on Jun 30, 2026

Similar Companies

Strand Life Sciences & 854 more

View Sirona Dx's full profile

Sirona Dx is a funded company. Sirona Dx has 1 institutional investor.

View details of Sirona Dx's funding rounds and investors

The founders of Sirona Dx is Nasry Yassa.

Here are the details of Sirona Dx's key team members:

Nasry Yassa: Co-Founder & CEO of Sirona Dx.
Contact Info: 1 email address and 1 phone number

View details of Sirona Dx's Founder profiles and Board Members

Sirona Dx's employee count trend

Sirona Dx has 12 employees as of Jun 26. Here is Sirona Dx's employee count trend over the years:

Uncover Sirona Dx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sirona Dx include Strand Life Sciences, BGI and ONCOHOST. Here is the list of Top 10 competitors of Sirona Dx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, Quadria Capital & 92 others	73/100
2nd	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Sequoia Capital China, Yunfeng Capital & 15 others	64/100
3rd	ONCOHOST 2017, Binyamina Giv at Ada (Israel), Series C	AI-based oncology therapy plan solution for professionals	$43M	ALIVE, OurCrowd & 5 others	60/100
4th	Enara Bio 2016, Oxford (United Kingdom), Series B	Developer of T-cell based cancer-cell interface for therapeutics	$84.1M	SV Health Investors, M Ventures & 36 others	53/100
5th	Genewiz 1999, South Plainfield (United States), Acquired	Provider of a wide range of genomic services for the life sciences industry	-	Orbimed, Ampersand Capital & 6 others	53/100
6th	Berry Genomics 2010, Beijing (China), Public	Provider of genetic testing products and tests	$16M	Legend Capital, TMCP & 6 others	50/100
7th	Axxam 2001, Milan (Italy), Acquired	Provider of services for research application across life sciences industries	-	Keensight Capital	48/100
8th	Dante Omics 2016, New York City (United States), Unfunded	Provider of genomic services and solutions for researchers, laboratories, and healthcare professionals	-	-	48/100
9th	Amplia Therapeutics 2000, North Melbourne (Australia), Public	Developer of therapies for treating cancer and pulmonary fibrosis	-	-	47/100
10th	Transnetyx 2000, Memphis (United States), Acquired	Developer of automated-genotyping services for murine cell lines	-	Abacus Finance Group, ventureCapital.org & 2 others	47/100
53rd	Sirona Dx 2014, Lake Oswego (United States), Funding Raised	Contract research organization offering a wide range of genomic services	-	OTRADI	39/100